共有 50 笔近期内部人交易记录记录,涉及 Harpoon Therapeutics, Inc. (HARP), 包括 36 笔买入 和 12 笔卖出. 内部人买入总额为 $494.5M 内部人卖出总额为 $2.38M.
近期活跃的重要内部人包括 Merck & Co., Inc., Bailes Joseph S, Silvernail Lauren P. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — HARP
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-03-11 |
Merck & Co., Inc. |
10 Percent Owner |
知情买入 |
21,397,205 |
$23.00 |
$492.14M |
1,000 |
| 2024-03-11 |
Bailes Joseph S |
Director |
股份退回 |
2,300 |
$6.66 |
$15.31K |
- |
| 2024-03-11 |
Silvernail Lauren P |
Director |
股份退回 |
2,300 |
$6.66 |
$15.31K |
- |
| 2024-03-11 |
Hunt Ronald |
10 Percent Owner |
股份退回 |
2,300 |
$6.66 |
$15.31K |
- |
| 2024-03-11 |
Myers Scott Dunseth |
Director |
股份退回 |
4,600 |
$6.66 |
$30.62K |
- |
| 2024-03-11 |
Eastland Julia Marie |
President and CEO |
股份退回 |
40,759 |
$8.90 |
$362.76K |
- |
| 2024-03-11 |
Drachman Jonathan G |
Director |
股份退回 |
2,300 |
$6.66 |
$15.31K |
- |
| 2024-03-11 |
Robbins Andrew R |
Director |
股份退回 |
2,300 |
$6.66 |
$15.31K |
- |
| 2024-03-11 |
Lanza Frank J |
Principal Fin. & Acctng Ofc. |
股份退回 |
8,643 |
$6.97 |
$60.24K |
- |
| 2024-03-11 |
Bucher James B |
Chief Legal Officer |
股份退回 |
110,000 |
$11.30 |
$1.24M |
- |
| 2024-03-11 |
Walker Luke Nathaniel |
Chief Medical Officer |
股份退回 |
10,000 |
$8.90 |
$89K |
- |
| 2024-03-11 |
Chin Mark |
Director |
股份退回 |
2,300 |
$6.66 |
$15.31K |
- |
| 2024-03-11 |
New Leaf Biopharma Opportunities Ii, L.p. |
10 Percent Owner |
股份退回 |
85,750 |
$5.83 |
$500.31K |
- |
| 2024-03-08 |
Hunt Ronald |
10 Percent Owner |
限制性股票授予 (RSU) |
424 |
- |
- |
13,224 |
| 2024-03-08 |
Drachman Jonathan G |
Director |
限制性股票授予 (RSU) |
415 |
- |
- |
5,415 |
| 2024-03-08 |
Chin Mark |
Director |
限制性股票授予 (RSU) |
424 |
- |
- |
13,224 |
| 2024-01-07 |
Eastland Julia Marie |
President and CEO |
限制性股票授予 (RSU) |
178,500 |
- |
- |
232,003 |
| 2024-01-07 |
Lanza Frank J |
Principal Fin. & Acctng Ofc. |
限制性股票授予 (RSU) |
15,000 |
- |
- |
18,362 |
| 2024-01-07 |
Walker Luke Nathaniel |
Chief Medical Officer |
限制性股票授予 (RSU) |
115,000 |
- |
- |
135,000 |
| 2024-01-07 |
Merck & Co., Inc. |
10 Percent Owner |
未知 |
- |
- |
- |
- |
| 2024-01-01 |
Hunt Ronald |
10 Percent Owner |
限制性股票授予 (RSU) |
1,072 |
- |
- |
12,801 |
| 2024-01-01 |
Myers Scott Dunseth |
Director |
限制性股票授予 (RSU) |
2,048 |
- |
- |
22,666 |
| 2024-01-01 |
Chin Mark |
Director |
限制性股票授予 (RSU) |
1,072 |
- |
- |
12,801 |
| 2023-12-21 |
Bucher James B |
Officer |
未知 |
- |
- |
- |
- |
| 2023-12-21 |
Bucher James B |
Chief Legal Officer |
限制性股票授予 (RSU) |
110,000 |
$11.30 |
$1.24M |
110,000 |
| 2023-11-27 |
Bailes Joseph S |
Director |
限制性股票授予 (RSU) |
5,000 |
- |
- |
5,000 |
| 2023-11-27 |
Silvernail Lauren P |
Director |
限制性股票授予 (RSU) |
5,000 |
- |
- |
5,000 |
| 2023-11-27 |
Hunt Ronald |
10 Percent Owner |
限制性股票授予 (RSU) |
5,000 |
- |
- |
11,729 |
| 2023-11-27 |
Myers Scott Dunseth |
Director |
限制性股票授予 (RSU) |
5,000 |
- |
- |
20,618 |
| 2023-11-27 |
Drachman Jonathan G |
Director |
限制性股票授予 (RSU) |
5,000 |
- |
- |
5,000 |
| 2023-11-27 |
Robbins Andrew R |
Director |
限制性股票授予 (RSU) |
5,000 |
- |
- |
5,000 |
| 2023-11-27 |
Chin Mark |
Director |
限制性股票授予 (RSU) |
5,000 |
- |
- |
11,729 |
| 2023-11-26 |
Eastland Julia Marie |
President and CEO |
限制性股票授予 (RSU) |
50,000 |
- |
- |
53,503 |
| 2023-11-26 |
Lanza Frank J |
Principal Fin. & Acctng Ofc. |
限制性股票授予 (RSU) |
2,000 |
- |
- |
3,362 |
| 2023-11-26 |
Walker Luke Nathaniel |
Chief Medical Officer |
限制性股票授予 (RSU) |
20,000 |
- |
- |
20,000 |
| 2023-10-25 |
Hunt Ronald |
10 Percent Owner |
知情买入 |
85,750 |
$5.83 |
$500.31K |
85,750 |
| 2023-10-25 |
New Leaf Biopharma Opportunities Ii, L.p. |
10 Percent Owner |
知情买入 |
85,750 |
$5.83 |
$500.31K |
85,750 |
| 2023-10-01 |
Hunt Ronald |
10 Percent Owner |
限制性股票授予 (RSU) |
3,035 |
- |
- |
6,729 |
| 2023-10-01 |
Myers Scott Dunseth |
Director |
限制性股票授予 (RSU) |
5,797 |
- |
- |
15,618 |
| 2023-10-01 |
Chin Mark |
Director |
限制性股票授予 (RSU) |
3,035 |
- |
- |
6,729 |
| 2023-07-01 |
Hunt Ronald |
10 Percent Owner |
限制性股票授予 (RSU) |
18,656 |
- |
- |
36,941 |
| 2023-07-01 |
Myers Scott Dunseth |
Director |
限制性股票授予 (RSU) |
35,634 |
- |
- |
98,215 |
| 2023-07-01 |
Chin Mark |
Director |
限制性股票授予 (RSU) |
18,656 |
- |
- |
36,941 |
| 2023-06-22 |
Bailes Joseph S |
Director |
限制性股票授予 (RSU) |
23,000 |
$0.67 |
$15.31K |
23,000 |
| 2023-06-22 |
Silvernail Lauren P |
Director |
限制性股票授予 (RSU) |
23,000 |
$0.67 |
$15.31K |
23,000 |
| 2023-06-22 |
Hunt Ronald |
10 Percent Owner |
限制性股票授予 (RSU) |
23,000 |
$0.67 |
$15.31K |
23,000 |
| 2023-06-22 |
Myers Scott Dunseth |
Director |
限制性股票授予 (RSU) |
46,000 |
$0.67 |
$30.62K |
46,000 |
| 2023-06-22 |
Drachman Jonathan G |
Director |
限制性股票授予 (RSU) |
23,000 |
$0.67 |
$15.31K |
23,000 |
| 2023-06-22 |
Robbins Andrew R |
Director |
限制性股票授予 (RSU) |
23,000 |
$0.67 |
$15.31K |
23,000 |
| 2023-06-22 |
Chin Mark |
Director |
限制性股票授予 (RSU) |
23,000 |
$0.67 |
$15.31K |
23,000 |
■ 知情交易 — 公开市场买卖(最具参考价值)
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期